CTRI/2019/12/022553尚未招募1 期
Parallel arm, clinical study to evaluate the Effectiveness, Safety and Tolerability of functional drinkNE-S01 in improving wellbeing, exercise efficacy and stamina in healthy and diabetic individuals. - Nil
aturedge Beverages Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Subject of age 18 to 60 years has a B.W in between 45 to 75 kg.
- •2. Subject is a non-smoker.
- •3. Subject is in good health and appropriate for exercise.
- •4. Subjects with diabetes mellitus type 2 with fasting blood sugar
- •between 120-180 mg/dl with or without ongoing oral hypoglycemic
- •5. Subject agrees to not use any new vitamins and/or minerals until
- •after study completion and to not take any vitamins and/or minerals
- •24 hours prior to the test visits.
- •6. Subject agrees to not use any dietary or herbal supplements until
- •after study completion. A 7-day washout is allowed for study
- •7. Subject is willing and able to comply with the protocol including:
- •Attending 3 visits; Refraining from caffeine, over-the-counter
- •medications and alcohol for the 24 hours prior to the test visits;
- •Refraining from taking any dietary or herbal supplements throughout
- •8. Subject is able to understand and sign the informed consent to
- •participate in the study.
排除标准
- •The subjects will be excluded based on the following criteria during
- •screening and during the study.
- •1. Subjects with or prior history or presence of clinically significant
- •Cardiovascular, pulmonary, hepatic, renal, hematological,
- •gastrointestinal, endocrine, immunologic, dermatologic,
- •musculoskeletal, neurological or psychiatric disease.
- •2. Subject has any orthopedic problem(s) or history of
- •musculoskeletal injury(ies).
- •3. Subject has a history of cancer (except localized skin cancer
- •without metastases) within 5 years prior to screening.
- •4. No prescription or chronic medication use allowed without PI
- •discretion.
- •5. Subject has an allergy to any of the ingredients in the test product.
- •6. Subject is currently taking and unwilling to refrain from taking any
- •over-the-counter stimulant medications/ supplements; seven-day
- •washout required for study inclusion.
- •7. Subject is currently taking and unwilling to refrain from taking any
- •over-the-counter allergy or asthma medication containing
- •pseudoephedrine or ephedrine; seven-day washout required for
- •study inclusion. 8. Subject reports being a regular caffeine consumer
- •defined as consuming > 600 mg of caffeine per day. 9. Subject has a
- •clinically relevant abnormality as defined by the PI or interpreting
- •physician with respect to the physical examination.
- •10. Subject has a history of drug or alcohol abuse in the past 12
- •11. Subject has any condition or abnormality that, in the opinion of
- •the investigator, would compromise the safety of the subject or the
- •quality of the study data.
- •12. Subject with type 1 diabetes
- •13. Subjects receiving insulin
研究者
相似试验
尚未招募
2 期
Clinical study of energy drink NE-S01 in improving wellbeing and staminaCTRI/2019/05/019406aturedge Beverages Pvt Ltd
尚未招募
4 期
A comparative study with two groups on treating GallstonesCTRI/2024/08/072534WHITE MEMORIAL HOMOEO MEDICAL COLLEGE AND HOSPITA
尚未招募
2 期
Clinical Study of a AVI- TR 01 ointment in Patients with arthritis of knee and low back ache.CTRI/2021/10/037470MN Pharmaceuticals
已完成
1 期
Clinical trial of Nutraceutical product Power Gummies : hair and nail vitamin.CTRI/2020/10/028698Aesthetic Nutrition Pvt Ltd60
尚未招募
2 期
Ayurvedic treatment for Heel pain.CTRI/2024/06/069324Rishikesh Ghodke